“…Anti-67-kDa elastin/laminin binding protein (67BP) monoclonal antibody (mAb) BCZ 67 (IgM) was kindly provided by Dr. R. P. Mecham (Pulmonary Research, the Jewish Hospital at Washington University, St. Louis, MO) [18]. Anti-E-selectin mAb 68-5H11 (IgG1) [19], anti-P selectin mAb AK4 (IgG1) [20], and anti-L-selectin mAb DREG-56 (IgG1) [21] were purchased from Pharmingen, San Diego, CA; anti-L-selectin mAb SK11 (available as Leu 8, IgG2a) [22], anti-CD44 mAb L178 (IgG1) [23], anti-CD18 mAb L130 (IgG1) [24], and anti-ICAM-1 (CD54) mAb LB-2 (IgG2b) [25] were from Becton Dickinson, San Jose, CA; anti-NCA90 (CD66c) mAb CLBgran10 (IgG1) [6] was from Sanbyo, Uden, The Netherlands; anti-CD4 mAb TH/1 (IgG1), anti-CD11a mAb SPV-L7 (IgG1) [26], anti-CD11b mAb Bear1 (IgG1) [26], anti-CD11c mAb FK24 (IgG1) [27], anti-CD18 mAb CLB-LFA-1 (IgG1) [28], anti-CD 29 mAb SG/I9 [29], anti-CD49d SG/73 [29], and anti-CD49e KH/33 [29] were from Seikagaku Corp., Tokyo, Japan; and anti-CD18 7E4 (IgG1) [30] and anti-CD66b 80H3 (IgG1) [31] were from Immunotech S.A., Marseille, France.…”